Cart (0 Items)
Your cart is currently empty.
View Products-
-
-
Ulocuplumab Biosimilar – Anti-CXCR4, CD184 mAb – Research Grade
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG4, kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Ulocuplumab Biosimilar - Anti-CXCR4, CD184 mAb - Research Grade |
|---|---|
| Source | CAS 1375830-34-4 |
| Species | Homo sapiens |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Ulocuplumab,BMS-936564, MDX-1338,CXCR4, CD184,anti-CXCR4, CD184 |
| Reference | PX-TA1339 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG4-kappa |
| Clonality | Monoclonal Antibody |
Description of Ulocuplumab Biosimilar - Anti-CXCR4, CD184 mAb - Research Grade
General information on Anti-CXCR4/CD184[Homo sapiens] (Ulocuplumab) Monoclonal Antibody
Ulocuplumab is investigated for the treatment of Solid Tumors.
Related products
Antigen
CD184 / CXCR4, N-His, recombinant protein
PX-P5587 392$
Isotype Control
Human IgG4 Isotype Control antibody
PTX17887 215$Contact us
Send us a message from the form below
Reviews
There are no reviews yet.